Biolab Farmacêutica to open GTA R&D centre

With an initial investment of BRL $20 million (approximately CAD $8 million) in equipment, facilities and technical staff, Biolab Farmacêutica, a 100 per cent Brazilian-owned company that ranks among the largest in the healthcare market in Brazil, announced the opening of a Research and Development (R&D) Centre in the Greater Toronto Area.

0 August 27, 2015
Staff

This investment is part of Biolab’s global expansion plans. In the initial stage, 20 specialized professionals will work in the new facility. The 1,000 square meter R&D centre will be an extension of Biolab’s Itapecerica da Serra R&D centre in Brazil, and the two operations will be fully integrated.

“When we started planning our R&D centre abroad, we wanted to set it up in an innovative region with incentives and openness to partnerships and business. We found these features in Ontario, which has the ideal conditions for us to move forward in our pursuit of cutting edge innovation,” said Biolab’s CEO, Cleiton de Castro Marques.

When making the decision to open a Canadian R&D Centre, Biolab received guidance from the commercial section at Canada’s Consulate General in São Paulo, the Commercial Consul of Ontario in Brazil, the City of Mississauga, and Invest Toronto.

This was an effective partnership among all three levels of government, and the collaborative support was crucial to securing this important investment in the life sciences sector for the Greater Toronto Area.


Leave a Reply

Your email address will not be published. Required fields are marked *

*